Low-density lipoprotein- cholesterol and its relation to epicardial fat volume in patients with type II diabetes mellitus

Authors

  • Asmaa A. Hasan
  • Ghada M. S. Ahmed
  • Bassem M. Abdel Hady
  • Inass H. Ahmed
  • Entesar O. El Saghier
  • Marwa F. M. El Sayed
  • Lamiaa H. Azel
  • Marwa A, Mohamed
  • Ola I. Saleh
  • Randa S. E. Taha
  • Mona A. Raafat
  • Ola H. Abd Elaziz

DOI:

https://doi.org/10.31989/bchd.v6i11.1235

Abstract

Objectives: This study aimed to compare EFV between diabetic and non-diabetic subjects in patients with clinical indications of CCTA and test the correlation between low-density lipoprotein-cholesterol (LDL-C) and EFV in type 2 diabetic (T2DM) patients.

Methods: This study was conducted on 103 cases with chest pain and intermediate risk probability for CAD and was scheduled for CT coronary angiography divided into 47 diabetic patients and 56 non-diabetic patients. The total serum cholesterol, LDL-C, TG, and HDL-C levels were analyzed for each patient. MDCT to assess CACS and EFV for patients included in the study. 

Results: The results showed thatplasma total cholesterol, TG, and LDL-C were higher with decreased HDL in the diabetic patient. EFV was significantly higher in diabetic patients (54.5±14.9 vs 44.7±7.7, p <0.02). EFV had a significant  Linear correlation with plasma total cholesterol, LDL-C, and TG. In contrast, there is a significant negative correlation between EFV and HDL-c. EFV was significantly correlated with ca score (EFV was higher in diabetic patients with greater CAC score). 

Conclusion: EFV is rising in type II diabetic patients, especially those with high ca scores, and correlates well to their characteristic hyperlipidemia, especially LDL-C. So, all diabetic patients must be started on primary prevention against LDL-C to reduce the risk of atherosclerosis. 


Keywords: Type II DM, Epicardial fat volume, LDL-c.

Downloads

Published

2023-11-24

Issue

Vol. 6 No. 11 (2023): November 2023

Section

Research Articles

License

Copyright (c) 2023 FFC/Bioactive Compounds in Health and Disease

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors retain the copyright of their articles and grant the Functional Food Center (FFC) and its journals the right of first publication under the terms of the Creative Commons Attribution 4.0 International License.

This license permits unrestricted use, distribution, and reproduction in any medium, including commercial use, provided the original author(s) and source are properly credited. Authors may post and share their published work freely, provided that the original publication in this journal is acknowledged.

By submitting to this journal, authors confirm that their manuscripts are original, not under consideration elsewhere, and that they hold the necessary rights to grant this license. The Functional Food Center encourages open scientific exchange and allows derivative and extended works, provided attribution to the original publication is maintained.